Highland Instruments, Inc. Announces New Award of SBIR Grant for Clinical Evaluation of Noninvasive Neural Stimulation Technology

Published: Sep 23, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BOSTON--(BUSINESS WIRE)--Highland Instruments, Inc., (“Highland”) today announced continuation of award for a multi-year SBIR Grant from the National Institutes of Health National Institute of Neurological Disorders and Stroke (“NIH-NINDS”) for the clinical evaluation of Highland’s ElectroSonic Stimulation (“ESStim™”) technology for the treatment of Parkinson’s Disease (“PD”)1. The main academic partner collaborator in this grant and location of the clinical trial will be Spaulding Rehabilitation (“Spaulding”) Hospital’s Laboratory of Neuromodulation (Boston). Felipe Fregni, MD, PhD, MPH, will be the Lead Clinical Investigator. Dr. Fregni is the Director of the Laboratory of Neuromodulation at Spaulding Rehabilitation Hospital and Associate Professor of PM&R and Neurology at Harvard Medical School.

Help employers find you! Check out all the jobs and post your resume.

Back to news